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The number of fluoroscopy-guided procedures in cardiology is increasing over time and it is appropriate to wonder whether tech-
nological progress or change of techniques is influencing patient exposure. The aim of this study is to examine whether patient
dose has been decreasing over the years. Patient dose data of more than 7700 procedures were collected from two cardiology
centres. A steady increase in the patient dose over the years was observed in both the centres for the two cardiological procedures
included in this study. Significant increase in dose was also observed after the installation of a flat-panel detector. The increasing
use of radial access may lead to an increase in the patient exposure. The monitoring of dose data over time showed a consider-
able increase in the patient exposure over time. Actions have to be taken towards dose reduction in both the centres.
INTRODUCTION
The number of interventional cardiology procedures
has increased over the years. Only in Europe, a 3.2-
fold increase in coronary angiograms from 1992 to
2004 was estimated, resulting in 2 million procedures
performed in 2004; more than 3 million procedures
are expected in 2010(1). In the same study, the trends
for both coronary angiography (CA) and stenting
were also observed to be rising. In the USA, the
number of percutaneous coronary interventions has
considerably increased without a simultaneous
change in patient demographics, which means that
more patients today are referred to interventional
procedures than open operations(2). Reasons for this
increase may include changes in patient demo-
graphics in some countries, increased operator
clinical skills, the development and availability of
purpose-designed cardiological fluoroscopic systems.
Many procedures that previously required open
surgery or were impossible are now safely and effec-
tively performed using interventional techniques.
However, there is significant concern related to the
radiation exposure of patients undergoing fluorosco-
pically guided procedures. Patients may suffer from
radiation-induced skin injuries (skin erythema, per-
manent epilation, skin necrosis) and if younger, the
risk of cancer may be significantly higher(3).
National and international authorities point to the
increasing number of fluoroscopy-guided procedures
and recommend patient dose surveys and the usage
of dose reference levels (DRLs) to optimise the
exposure(3,4). The aim of this study was to examine
if radiation doses tend to increase or decrease over
the years and investigate whether new technology
and techniques have an impact on the dose delivered
to patient.
MATERIALS AND METHODS
The survey took place in two large cardiology
centres (A and B). Two procedures were chosen to
be analysed: CA and percutaneous transluminal
coronary angioplasty (PTCA). Annual data for the
two procedures were collected from each centre,
including values of dose–area product (DAP) and
fluoroscopy time (T ). Data for centre A were col-
lected from 2001 to 2007 and for centre B from 2004
to 2007. In centre A, the fluoroscopy unit Integris
(Philips Medical System, The Netherlands) was
equipped with a 23-cm image intensifier (II). In
2004, a new unit Allura XPS FD10 (Philips Medical
System, The Netherlands) was installed, equipped
with a flat-panel detector (FPD). This change in
installation was taken into consideration during the
data analysis. In centre B, a fluoroscopy unit
Diagnos Poly 2C (Philips Medical System, The
Netherlands) was also equipped with a 23-cm II. In
both the centres, a DAP meter was installed on the
X-ray equipments. In centre B, patient data included
information about the vascular access approach
(femoral or radial access). The difference in the two
approach techniques was examined for their
effect on radiation dose. For each procedure, the
mean, median, maximum and 75 % values were
established. Non-parametric analysis [Mann–
Whitney U (M–W) test] was used to compare the
differences between the results. Statistical data analy-
sis was performed with the SPSS 15 software
package (SPSS Inc, Chicago, IL, USA).
RESULTS
In total, data from 4742 procedures were collected
from centre A and 3027 procedures from centre B.
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The results for the DAP values in the CA and
PTCA procedures are presented in Tables 1 and 2
and the fluoroscopy times T are shown in Tables 3
and 4, respectively. The 75 % values were used to
compare the differences between patient doses over
the years. A 2.5- and 1.7-fold increase was observed
for the DAP values during CA procedure in centres
A and B, respectively. Statistically significant
increase in the DAP values was observed between
2004 and 2005, when the FPD was installed.
However, the DAP values were shown to be signifi-
cantly higher every year since 2004. T has also
increased over the years in both the centres. The
DAP values have also increased with respect to
PTCA procedures. This increase was found to be
statistically significant for both the centres. However,
the T values were found to be constant over time for
centre A. In centre B, T showed a significant
decrease especially between 2005 and 2006
( p-value ¼ 0.009).
A small increase in the number of cases treated
with radial access was observed for centre B
(Figure 1). The results were compared by M–W test
to test any significant difference in patient dose
between the radial and femoral access. A significant
difference was confirmed in the case of CA for
both DAP (Z ¼ 4.317, p-value , 0.001) and T (Z ¼
5.669, p-value , 0.001). The results for PTCA
procedures were not found to be significantly
different (DAP: Z ¼ 0.072, p-value ¼ 0.943 and T:
Z ¼ 0.358, p-value ¼ 0.721).
DISCUSSION
Contrary to the expectations, the present work
shows that radiation doses in cardiology procedures
have increased over time in the two centres moni-
tored despite the fact that the staff remained the
same and all operators were senior interventionists.
On the other hand, fluoroscopy time was found to
remain constant or has slightly decreased during the
same period.
The DRLs concept was proposed in 1990
by International Commission on Radiological
Protection (ICRP) and is accepted as a management
tool for radiation exposure in medical imaging pro-
cedures. The main objective of the DRLs is patient
dose reduction for a given examination. DRLs
should be used to ensure a balance between patient
dose and image quality. It is essential to be
monitored over time. The use of this concept is
straightforward in radiography or CT examinations;
however, it presents some limitations when it is used
in fluoroscopy where the procedures are less standar-
dised. In 2008, the Swiss Federal Office for public
health published DRLs for diagnostic and thera-
peutic procedures in radiology and cardiology. The
DRLs in terms of DAP and T, for CA are
Table 1. Mean, median, 75 % percentile and maximum values of DAP (Gy.cm2) for CA procedures.
Centre A Centre B
Mean Median 75 % Maximum Z P-value Mean Median 75 % Maximum Z p-value
2001 30 25 35 255 1.593 0.111 — — — — — —
2002 31 25 38 197 1.725 0.103 — — — — — —
2003 33 26 40 260 1.654 0.098 — — — — — —
2004 39 29 47 361 2.720 0.101 40 31 50 33 1.649 0.099
2005 48 40 63 229 5.726 ,0.001 72 35 66 95 5.978 ,0.001
2006 61 52 81 345 6.258 ,0.001 118 49 87 413 1.298 0.194
2007 62 55 86 235 — — 102 54 86 579 — —
Table 2. Mean, median, 75 % percentile and maximum values of DAP (Gy.cm2) for PTCA procedures.
Centre A Centre B
Mean Median 75 % Maximum Z p-value Mean Median 75 % Maximum Z p-value
2001 60 54 75 241 0.675 0.500 — — — — — —
2002 63 51 77 252 2.975 0.301 — — — — — —
2003 62 53 81 356 1.875 0.061 — — — — — —
2004 63 53 85 2043 7.673 ,0.001 121 88 152 1540 0.688 0.492
2005 132 110 177 746 3.734 ,0.001 126 99 159 1310 4.008 ,0.001
2006 166 137 214 1214 6.521 ,0.001 264 112 209 7990 1.920 0.055
2007 201 144 288 986 — — 212 127 199 9840 — —
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70 Gy.cm2 and 7 min and for PTCA 100 Gy.cm2
and 20 min, respectively. The comparison of the
DRLs with the 75 % of DAP and T showed that
national DRLs were exceeded in both the centres. In
centre A, the DAP values were below the DRL
values from 2001 to 2005 and from 2001 to 2004 for
CA and PTCA, respectively. For CA procedures, the
DRLs were surpassed 14 and 18 % in 2006 and
2007, respectively. In the case of PTCA, the DRLs
were exceeded more than 80 % the last 3 y. However,
the DRLs for the T were not exceeded for CA and
were exceeded 5 % only in 2007 for PTCA. For
centre B, in the CA procedures the DRLs were sur-
passed in 2006 and 2007. The DAP values for
PTCA were found to be consistently higher than the
DRLs. The main concern is that DAP values
exceeded the DRLs and they are continuously
rising. Clearly, something must be done with respect
to dose optimisation.
Concerning centre A, it appears that during the
years 2001–03 the annual DRLs were systematically
well under the DRLs adopted in Switzerland for
cardiac procedures. A significant increase in dose
was observed in 2004, when the conventional II was
replaced by a FPD. Differences in T were not found
to be statistically significant, suggesting that pro-
cedures of a similar complexity were performed.
In centre A, even with superior technology
installed, doses steadily increased from 2004 to
2007, exceeding the national DRLs in Switzerland.
Centre A, in which patient exposure was significantly
lower than centre B in the past, is now overtaking
centre B where a conventional II is still in use. Dose
rate measurements were performed in order to
understand the cause of such dose increases in
centre A and the values obtained were comparable
with dose rates delivered with the previous technol-
ogy. No major differences were noticed at that
level. One of the main problems was, and
certainly remains, the X-ray beam collimation.
Figure 1. Percentage of radial access in centre B for years
2004–07.
Table 4. Mean, median, 75 % percentile and maximum values of T (min) for PTCA procedures.
Centre A Centre B
Mean Median 75 % Maximum Z p-value Mean Median 75 % Maximum Z p-value
2001 9.7 8.2 11 39 1.203 0.229 — — — — — —
2002 9.8 7.6 11 46 2.542 0.203 — — — — — —
2003 9.7 7.8 13 52 15.399 ,0.001 — — — — — —
2004 13 8.0 14 84 1.752 0.080 26 15 25 324 0.611 0.541
2005 10 8.4 13 43 1.598 0.110 17.2 14 23 75 2.611 0.009
2006 11 9.2 14 66 2.310 0.101 16 13 20 87 1.742 0.082
2007 13.2 9.1 21 52 — — 14 11 19 58 — —
Table 3. Mean, median, 75 % percentile and maximum values of T (min) for CA procedures.
Centre A Centre B
Mean Median 75 % Maximum Z p-value Mean Median 75 % Maximum Z p-value
2001 3.7 2.5 2.4 50.6 2.128 0.033 — — — — — —
2002 3.7 2.8 4.6 31.4 6.542 0.056 — — — — — —
2003 3.8 2.6 4.8 35 21.48 ,0.001 — — — — — —
2004 5.7 3.0 5.0 89 6.579 ,0.001 9.2 3.5 7.7 305 2.031 0.042
2005 3.4 2.6 3.8 22 3.503 ,0.001 6.7 4.4 7.0 115 2.038 0.042
2006 4.0 2.9 5.0 39 6.128 ,0.001 5.9 4.0 6.6 82 0.492 0.622
2007 4.2 3.1 5.1 65 — — 5.7 4.0 6.3 85 — —
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Interventionists tend to use larger fields of view,
since the dynamic range of the FPD does not lead
to inadequate image quality even when lung tissue is
present in the image. Beam collimation cannot fully
explain the continuous increase in patient dose. An
increase over time (especially for CA as shown in
Figure 1) of the radial access instead of the standard
femoral access was noticed. Radial access is a rela-
tively new approach technique, which is clinically
advantageous for the comfort of the patient. It also
allows shorter hospitalisation of the patient leading
to a significant cost reduction. One of the main
inconveniences of the radial approach, even though
this is still under controversy, is that it may increase
patient dose as well as staff dose. As an example,
radial access has been shown to result in higher
doses to patients in the case of CA, but not in the
case of PTCA. Larrazet et al.(5) reported higher
DAP values and fluoroscopy time with radial access
than with femoral access during PTCA procedures.
However, their study was not randomised. Sandborg
et al.(6) also reported higher exposure with radial
artery access in CA and coronary interventions.
Higher values in the cases with radial access were
also found in the study by Philippe et al.(7). On the
contrary, Geijer and Persliden(8) reported no differ-
ence in radiation dose between the two different
techniques for interventional procedures.
The use of DRLs in fluoroscopy is associated with
certain limitations; the main one being that they do
not take into account the complexity of the pro-
cedure (e.g. elective or emergency procedure, mono-
or multi-vessels procedure, etc.). This might be
improved in the near future since several groups(9,10)
have proposed introducing complexity indices to
refine the DRL values and thus increase its
acceptance in the clinical world. In spite of these
limitations, the results of this study, that are based
on the analysis of the DRL values over time, clearly
demonstrate that a major effort has to be made to
ensure patient safety in cardiology. In the present
study, the dose increase cannot be explained only by
a drastic increase in the complexity of the procedure.
The population demographics considered during this
survey and the personnel of the centres remained the
same.
CONCLUSION
In conclusion, radiation doses in cardiology pro-
cedures performed under fluoroscopy guidance
appeared, in the case here, to increase over time and
basic rules of practical radiation protection have to
be re-introduced among the interventionists. This
has been demonstrated using the DRL concept even
if this concept has to be used with care since at the
moment it does not take into account procedural
complexity. In these high-dose procedures, it should
be a priority that medical physicists be involved to
ensure patient and personnel safety. Technological
progress is not directly associated with patient dose
reduction.
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